Brief: Gentian Diagnostics Q3 EBITDA Up At NOK 8.4 Million
23/10/2025 07:08
Oct 23 (Reuters) - Gentian Diagnostics ASA GENT.OL: EBITDA OF NOK 8.4 MILLION IN 3Q25 VERSUS NOK 5.0 MILLION IN 3Q24 SALES UP 28% TO NOK 41.8 MILLION IN 3Q25 Source text: ID:nObiYqWwYa Further company coverage: GENT.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company